Although primarily associated with ovarian malignancies, cancer antigen 125 (CA125) has demonstrated independent prognostic significance in CRC, occasionally exhibiting superior predictive capability compared with traditional CEA measurements [13]. The gene discussed is CEACAM5; the disease is colorectal carcinoma.